Overview

Norspan Transdermal Patches Study in Osteoarthritis Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a single center, open label, randomized, parallel group single dose pharmacokinetic (PK) study.
Phase:
Phase 1
Details
Lead Sponsor:
Mundipharma (China) Pharmaceutical Co. Ltd
Treatments:
Buprenorphine